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Abstract
Background: Stargazin (γ2) and the closely related γ3, and γ4 transmembrane proteins are part of
a family of proteins that may act as both neuronal voltage-dependent calcium channel (VDCC) γ
subunits and transmembrane α-amino-3-hydroxy-5-methyl-4-isoxazoleproponinc (AMPA)
receptor regulatory proteins (TARPs). In this investigation, we examined the distribution patterns
of the stargazin-like proteins γ2, γ3, and γ4 in the human central nervous system (CNS). In addition,
we investigated whether human γ2 or γ4 could modulate the electrophysiological properties of a
neuronal VDCC complex transiently expressed in Xenopus oocytes.
Results:  The mRNA encoding human γ2 is highly expressed in cerebellum, cerebral cortex,
hippocampus and thalamus, whereas γ3 is abundant in cerebral cortex and amygdala and γ4 in the
basal ganglia. Immunohistochemical analysis of the cerebellum determined that both γ2 and γ4 are
present in the molecular layer, particularly in Purkinje cell bodies and dendrites, but have an inverse
expression pattern to one another in the dentate cerebellar nucleus. They are also detected in the
interneurons of the granule cell layer though only γ2 is clearly detected in granule cells. The
hippocampus stains for γ2 and γ4 throughout the layers of the every CA region and the dentate
gyrus, whilst γ3 appears to be localized particularly to the pyramidal and granule cell bodies. When
co-expressed in Xenopus oocytes with a CaV2.1/β4 VDCC complex, either in the absence or
presence of an α2δ2 subunit, neither γ2 nor γ4 significantly modulated the VDCC peak current
amplitude, voltage-dependence of activation or voltage-dependence of steady-state inactivation.
Conclusion: The human γ2, γ3 and γ4 stargazin-like proteins are detected only in the CNS and
display differential distributions among brain regions and several cell types in found in the
cerebellum and hippocampus. These distribution patterns closely resemble those reported by
other laboratories for the rodent orthologues of each protein. Whilst the fact that neither γ2 nor
γ4 modulated the properties of a VDCC complex with which they could associate in vivo in Purkinje
cells adds weight to the hypothesis that the principal role of these proteins is not as auxiliary
subunits of VDCCs, it does not exclude the possibility that they play another role in VDCC
function.
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Background
The mutation underlying the absence epilepsy phenotype
of the allelic stargazer (stg) and waggler (wag) mutant
mice occurs in a gene, cacng2, whose product, stargazin,
has been hypothesized to be a neuronal voltage depend-
ent calcium channel (VDCC) γ subunit [1]. VDCCs are
intrinsically involved in the regulation of a multiplicity of
Ca2+ dependent processes in many different cell types
where they are inserted into the plasma membrane as het-
ero-oligomeric complexes of a pore-forming α1 subunit
with auxiliary β, α2δ and possibly γ subunits [2].
The first VDCC γ subunit to be identified (γ1) [3–5] was
found to be solely expressed in skeletal muscle, where its
function is to limit calcium entry through the L-type
VDCCs of skeletal myotubes [6,7]. VDCCs purified from
neuronal tissues did not appear to possess a γ subunit [8–
11]. However, despite sharing only weak protein sequence
identity with γ1 (25%), stargazin (γ2) was suggested to rep-
resent the first example of a neuronal VDCC γ subunit
based on its similar tetra-spanning transmembrane struc-
ture to the γ1 subunit and its ability to weakly modulate
VDCC-current properties in vitro [1]. Subsequent investi-
gations have identified six other stargazin-like genes
which are currently classified as cacng3-cacng8 (encoding
proteins γ3 - γ8), in a continuation of the VDCC γ subunit
nomenclature [12–17].
Investigation of the functional influence of these star-
gazin-like  γ proteins upon VDCCs has yielded mixed
results. Some laboratories have reported that γ2 and its
close homologue γ4 cause small hyperpolarizing shifts in
the voltage dependence of steady-state inactivation
[1,14,18]. This however, might be dependent upon which
other auxiliary subunits are co-expressed in the VDCC
complex under investigation [18]. In contrast, Chen et al.
[19] showed whole cell VDCC currents from the cerebellar
granule cells of stg mice, which effectively lack the γ2 sub-
unit, do not have significantly altered voltage-dependence
of activation or inactivation compared to wild type. Other
laboratories reported that γ2 or γ3 can significantly reduce
peak current amplitudes of N-type VDCCs expressed in
Xenopus oocytes, but only when co-expressed with an α2δ1
subunit [20], and supporting this, that thalamic relay neu-
rons from stg mice express enhanced low and high volt-
age-activated VDCC currents compared to wild type [21].
Furthermore, clear biochemical evidence has been gener-
ated for a direct interaction of γ2 with the VDCC CaV2.2 α1
subunit [20,22]. Another stargazin-like protein, γ7, which
is phylogenetically distinct from γ2,  γ3 and  γ4 [13,15],
almost abolishes the expression of CaV2.2 when co-
expressed  in vitro, and also reduces Ca2+  currents via
CaV1.2 and CaV2.1 channels [15]. However, our data indi-
cated that the influence of γ7 on VDCC function is to
reduce α1 subunit protein expression, a functional prop-
erty unlike anything reported for the other stargazin-like
proteins, which suggests that γ7 is not a subunit of a cal-
cium channel complex [15].
Whilst controversy surrounds the role of the γ2, γ3 and γ4
stargazin-like proteins in relation to VDCC modulation, a
clear function has been determined for these proteins as
chaperones for the appropriate trafficking and receptor
biogenesis of alpha-amino-3-hydroxy-5-methylisoxazole-
4-propionic acid (AMPA) receptors [19,23–25]. Conse-
quently, these three proteins together with their close
homologue  γ8, were recently dubbed transmembrane
AMPA receptor regulatory proteins (TARPs) [25]. A pri-
mary interaction (probably via transmembrane and/or
extracellular regions [26]) promotes the trafficking of the
GluR subunits to the plasma membrane, and a secondary
interaction of the C-terminus of stargazin with PSD-95 or
a similar cytoskeletal protein via a PSD-95/DLG/ZO-
1(PDZ)-binding motif facilitates the lateral relocation of
the glutamate receptor complex to its correct position in
the post-synaptic density [19] and hence influences the
number of AMPA receptors located at this site [27].
Elucidation of the differential distribution of the star-
gazin-like proteins coupled with studies of the physiolog-
ical abnormalities underlying the epilepsy phenotypes of
the mice expressing what are effectively null mutations of
γ2 has also helped to determine some of the normal func-
tions of these proteins in the murine CNS. The stg and wag
mice display a loss of the fast component of EPSC at
mossy fiber to cerebellar granule cell synapses [28,29],
plus reduced synaptic transmission at parallel fiber
Purkinje cell synapses in wag [29]. However, the synaptic
transmission to CA1 pyramidal cells (Schaffer collateral
projection) in stg is not altered [28]. In situ hybridization
studies have determined that murine γ2  is normally
expressed at its highest levels in the cerebellum [1,14,19].
γ3 and γ4 mRNAs are also detected in mouse cerebellum
but γ3 mRNA has been detected only in the Golgi neurons
of the granule cell layer and is absent from the molecular
layer [19]. γ4 mRNA is localized to the Purkinje, rather
than the granule cell layer [14]. Whilst this manuscript
was in preparation, Tomita et al. [25] reported that γ2 is
the only TARP expressed in rat cerebellar granule cells, but
like mouse, all isoforms are detected in hippocampus
[1,14,19,25]. The genetic defect in stg results in the loss of
γ2 mRNA and protein and does not appear to result in up-
or down-regulated expression of γ3 or γ4 [1,22]. Collec-
tively, these data suggest that stg mice exhibit the loss of
fast synaptic transmission in the mossy fiber to granule
cell synapse because γ2 is the major and possibly the only
stargazin-like protein in the cerebellar granule cells of
wild-type mice and no other stargazin-like protein is
expressed at sufficient levels to rescue normal AMPA
receptor trafficking and maturation. The reason thatBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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synaptic transmission to CA1 pyramidal cells in stg mice
is preserved is probably because, although γ2  is not
expressed in stg, the total remaining TARP expression lev-
els in hippocampal CA1 pyramidal cells are adequate to
promote normal surface expression of mature AMPA
receptors at the postsynaptic membrane in this synapse.
It was therefore of great interest to examine whether the
expression patterns of the human stargazin-like proteins
paralleled those of mouse and if they were differentially
expressed in the various cell types of each tissue. This
study presents the differential distribution of γ2, γ3 and γ4
in human brain by northern blotting and more detailed
immunohistochemical analysis of their expression in
human cerebellum and hippocampus. In addition, we
used the results of our distribution study to investigate
whether the human γ2 and γ4 could modulate currents
gated by a VDCC complex heterologously expressed in
Xenopus  oocytes that was assembled from the major
VDCC subunits expressed in a cerebellar Purkinje cell.
Results
Northern Blot analysis of mRNA distribution
The overall tissue distribution of human γ2,  γ3 and  γ4
mRNAs was analyzed by northern blotting. Specific cDNA
probes representing each gene were generated as
described in the methods and hybridized against a human
multiple-tissue northern blot (Figure 1A) and two brain
region blots (Figure 1B and 1C). The γ2-specific cDNA
probe detected two mRNAs of approximately 7 kb and 3
kb. Bands of similar size were reported in a mouse multi-
ple-tissue blot probed with a murine γ2 cDNA probe [1].
Like mouse, the human γ2 mRNA transcripts were detected
only in brain (Figure 1A), and were particularly abundant
in cerebellum, cerebral cortex, occipital lobe, frontal lobe
and temporal lobe, hippocampus and thalamus (Figure
1B and 1C). γ2 transcripts were detected at somewhat
lower levels in medulla, putamen, amygdala and substan-
tia nigra but only weakly in caudate nucleus. γ2 transcripts
were absent from corpus callosum and the sub-thalamic
nucleus and spinal cord.
A γ3 cDNA probe detected one 2.0–2.1 kb γ3 mRNA tran-
script which like γ2, was exclusively localized to the brain
(Figure 1A). However, γ3 mRNA was detected only in cer-
ebral cortex, including occipital lobe, frontal lobe, and
temporal lobe, the putamen, caudate nucleus, amygdala
and hippocampus and was absent from all of the other
regions probed (Figure 1B and 1C).
The  γ4-specific probe identified an mRNA of approxi-
mately 4 kb detected exclusively in brain (Figure 1A). This
was widely detected throughout the brain but was most
prevalent in the putamen and caudate nucleus. Unlike γ2
or γ3, γ4 mRNA was also weakly detected in spinal cord.
Generation and characterization of γ specific antisera
In order to investigate the distribution of the γ2, γ3 and γ4
proteins and to analyze their expression in different neu-
ronal cell types we generated specific antisera against each
isoform. These were generated using peptide immuno-
gens that were selected to be subtype-specific as deter-
mined by multiple sequence alignment. To confirm
activity against the corresponding holopeptide and lack of
cross-reactivity with the other subtypes, each of these
antisera were validated against the different subunit pro-
teins recombinantly expressed in COS-7 cells. Cells were
transiently transfected with a pMT2 expression vector con-
taining either the human γ2, γ3 or γ4 cDNAs, and 2–3 days
later were analyzed by immunocytochemistry. All three γ
isoforms could be readily detected and were localized
largely in the plasma membrane of the cells (Figure 2A).
The specificity of the antibodies (Abs) was confirmed by
incubating non-transfected cells with each primary Ab,
which in each case gave no immunoreactivity (Figure 2B).
Similar results were obtained when cells expressing one of
the γ isoforms were incubated with Abs directed against
either of the other two γ proteins (data not shown). Cells
transfected with a γ cDNA but which were not perme-
ablized after fixation also exhibited no immunoreactivity
(Figure 2C). Since the peptide sequences chosen for
immunization are in the C-terminus, these results indicate
this portion of recombinantly expressed γ2, γ3 and γ4 is
located intracellularly. Co-transfection of VDCC subunits
CaV2.1 and β4 did not alter the expression pattern of the γ
proteins indicating that there are no effects on trafficking
and that the anti-γ Abs did not cross-react with the CaV2.1
or β4 subunits (data not shown).
Immunolocalization of γ2, γ3 and γ4 in human cerebellum 
and hippocampus
Immunohistochemical analysis was carried out to exam-
ine the differential expression of γ2, γ3 and γ4 in human
cerebellum and hippocampus. Control experiments to
measure non-specific binding to tissue sections were per-
formed by pre-absorbing antisera overnight with 100 µM
of the relevant peptide (Figures 3E and 3I, 4C and 4D, 5C
and 5D and 6B) and by omitting the primary antibody
(data not shown).
Cerebellum
Figure 3 shows the pattern of staining observed in the cer-
ebellum using γ2, γ3 and γ4 specific antisera. Moderate γ2-
specific staining was seen in the molecular layer suggest-
ing expression in the dendrites of cerebellar Purkinje neu-
rons (Figure 3A). Small cell bodies in the molecular layer
that were most likely stellate or basket cell interneurons
also stained positively. The γ2 immunostaining was also
strong in the soma of Purkinje neurons extending to the
dendrites, but decreasing in intensity following the first
few bifurcations (Figure 3A). Cerebellar granule cells wereBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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Northern blot analysis of the human γ2, γ3, and γ4 mRNA transcripts Figure 1
Northern blot analysis of the human γ2, γ3, and γ4 mRNA transcripts. A. Human multiple-tissue northern blots 
revealed that the γ2, γ3, and γ4 are exclusively detected in the brain. B & C. Brain region blots determined that the γ2 and γ4 are 
almost ubiquitously expressed, but at differential levels in the same tissues. γ3 is more specifically localized to cerebral cortex, 
amygdala, caudate nucleus and hippocampus. Size markers were from an RNA ladder provided on the blot by BD Biosciences 
Clontech and the β-actin control probe results are displayed in the bottom panels.
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moderately stained for γ2 (Figure 3B), although assess-
ment of immunostaining in this cell type was difficult
since the majority of cell volume is comprised of the
nucleus. The strongest γ2 immunostaining in this region
was actually in the interneurons. Figure 3C shows strong
γ2 immunostaining in the cell bodies of the dentate cere-
bellar nucleus with only weak to moderate staining in the
surrounding neuropil.
Very weak γ3 staining was observed in Purkinje cell bodies
and in the interneurons of the granule cell layer (Figure
3D). Staining of the molecular layer neuropil and the
granule cells is comparable to the peptide pre-absorption
control (Figure 3E). It is therefore possible that the γ3 pro-
tein is poorly represented in these particular cell types and
not completely absent from the cerebellum. No γ3 immu-
noreactivity was observed in the dentate cerebellar
nucleus (data not shown).
Staining of a human cerebellar folium for γ4 is shown in
Figure 3F. The molecular layer and adjacent granule cell
layer was lightly to moderately stained, but the staining of
the Purkinje cell bodies and dendrites was striking. γ4
immunostaining extended well into the Purkinje cell den-
dritic arbors from the cell body indicating that γ4
expressed well throughout this cell type. The cell bodies
that stained positively in the molecular layer were small
interneurons. In the granule cell layer the interneurons
stained strongly for γ4 whereas the granule cells appear
unstained (Figure 3G). In the dentate cerebellar nucleus
(Figure 3H), γ4 immunostaining was detected strongly in
the perisomatic neuropil with only weak staining in the
cell bodies. Interestingly, this staining pattern was almost
the complete inverse of the γ2 immunostaining in the
same region (Figure 3C).
Hippocampus and dentate gyrus
Immunohistochemistry revealed differential expression
patterns for γ2, γ3 and γ4 in the different regions and cell
types of human hippocampus and dentate gyrus (Figure
4, 5 and 6). When incubated with the anti-γ2 Ab, general-
ized staining of the cell layers and neuropil throughout
the hippocampal formation was observed. In Figure 4A
the alveus, stratum oriens most adjacent to the CA1
pyramidal layer, and the pyramidal layer all stained mod-
erately for γ2. The stratum radiatum and lacunosum-
moleculare stained much more weakly. The CA2 and CA3
pyramidal layers stain well for the γ2 subunit (Figure 4B)
and the intensity of staining in the alveus increased
slightly in this region. It is however apparent that there is
only a very weak staining of the strata oriens and radiatum
in the CA2/3 regions; yet, moderate immunostaining is
detected in the stratum lucidum. Weak staining is visible
in the stratum lacunosum-moleculare. In the same section
we also observed moderate γ2 staining in the molecular
layer of the dentate gyrus and strong immunostaining in
the granule cells (examined at higher magnification on
Figure 4H). The γ2 staining was weak or absent in the pol-
ymorphic layer, but distinct fibers were stained which
course across this region. Moderate staining of cell bodies
in CA4 was also observed (Figure 4B, top left portion of
the panel). Pre-absorption controls using the γ2 peptide
immunogen (Figures 4C and 4D) show the background
staining in a serial section of the same hippocampus as in
Figures 4A and 4B. The perisomatic staining in the stratum
pyramidale, in the region of the CA1 towards the CA2 was
moderate, with slightly more intense somatic staining
(Figure 4E). An apparently higher level of γ2 staining in the
CA2 and CA3 regions (Figures 4F and 4G) compared to
CA1 was probably due to a higher density of pyramidal
cell soma in these regions compared to the CA1 region
[30].
Staining for γ3 was absent from the alveus, stratum oriens,
stratum radiatum and lacunosum-moleculare, but the
pyramidal layer of the CA1, CA2 and CA3 regions of
Transient expression of γ2, γ3, and γ4 in COS-7 cells Figure 2
Transient expression of γ2, γ3, and γ4 in COS-7 cells. A. 
Positive staining for γ2, γ3, or γ4 (red) is strongly localized to 
the membranes of permeablized cells transfected with the 
individual γ2, γ3, or γ4 cDNAs. Little immunostaining is 
observed in the cytoplasm between the membrane and 
nucleus (blue). B. Non-transfected cells did not stain for γ2, 
γ3, or γ4 using the Abs generated in this study. C. Cells trans-
fected with γ2, γ3, or γ4 cDNA, but not permeablized during 
the staining process do not show immunoreactivity for the 
appropriate anti-γ Abs. D. When co-transfected together 
with the CaV2.1 and β4 VDCC subunit cDNAs, the expres-
sion patterns of γ2, γ3, or γ4 were unaltered. Scale bars in all 
panels represent 10 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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Expression of the γ2, γ3, and γ4 stargazin-like proteins in human cerebellum Figure 3
Expression of the γ2, γ3, and γ4 stargazin-like proteins in human cerebellum. A. γ2 immunoreactivity in the molecular 
layer (m) and part of the adjacent granule cell layer (g) in a cerebellar folium. Strong γ2 immunostaining was seen in the 
Purkinje cell somata (p) that continued into the dendrites, observed as moderate staining of the molecular layer neuropil. Cell 
bodies in the molecular layer with positive γ2 immunoreactivity are small interneurons (i). B. In the granule cell layer, the gran-
ule cells (g) are moderately stained for γ2 although the strongest immunostaining in this region is actually in the interneurons 
(i). C. The dentate cerebellar nucleus (dcn), displayed strong γ2 immunostaining in the cell bodies of this nucleus with only 
weak to moderate staining in the surrounding neuropil. In this particular section, cell nuclei are stained blue by Mayer's hema-
toxylin counterstain. D. Cerebellar folia displayed little to no γ3 immunostaining in the central white matter (wm) and molec-
ular layer (m). Weak immunostaining was observed in the Purkinje cell bodies and the interneurons of the granule cell layer 
(g). E. Pre-absorption control, with the peptide immunogen for the γ3 Ab in the adjacent section to Fig. 3D. F. The cell bodies 
of the Purkinje cells (p) stained strongly for γ4 and this extended well into the Purkinje cell dendrites (d). The surrounding 
molecular layer neuropil (m) displayed light-moderate staining, as did the granule cell layer (g). Cell bodies in the molecular 
layer immunoreactive to the γ4 Ab were small interneurons (i). G. Granule cell layer interneurons (i) stained much more 
strongly for γ4 than the granule cells (g). H. The dcn gave a strong γ4 immunostaining signal in the perisomatic neuropil with 
only weak staining in the nucleus cell bodies. I. Immunizing peptide pre-absorption control for the γ2 Ab. Pre-absorption of the 
γ3 or γ4 Abs with their immunizing peptides produced almost identical results. Scale bars in all panels represent 25 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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γ2 immunohistochemistry in human hippocampus Figure 4
γ2 immunohistochemistry in human hippocampus. A. In the CA1, alveus (a), stratum oriens (o) most adjacent to the 
pyramidal layer, and the pyramidal layer (p) all stain moderately for γ2. The stratum radiatum (r) and lacunosum-moleculare (l-
m) stain much more weakly. B. Strong detection of γ2 protein occurred in the alveus and pyramidal layers of CA2 and CA3 
regions. Moderate immunostaining is detected in stratum lucidum (l). Staining of the strata oriens and radiatum was very weak 
in this region. The dentate gyrus molecular layer (ML) stains moderately for γ2 and the granule layer strongly (GL). γ2 staining 
is weak or absent in the polymorphic layer (PL). Cells in the CA4 show moderate staining. C and D. Serial sections to those 
displayed in panels A and B incubated with synthesis peptide pre-absorbed γ2 Ab. E. In the region of the CA1 towards the CA2 
the perisomatic staining is light to moderate with similar staining of the cell bodies. F. In the CA2, staining of neuropil and cell 
bodies is more intense than in CA1. G. Staining of the soma of the CA3 hippocampal neurons is strong with moderate staining 
of the surrounding neuropil. H. The dentate gyrus shows moderate staining of the molecular layer and dense immunostaining 
in the granule layer. The polymorphic layer is weakly stained. Scale bar in panels A–D represents 250 µm, in panels E–H 25 
µm. The dotted lines in panels A and B represent the border between the CA4 region of the hippocampus and the polymor-
phic layer of the dentate gyrus.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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γ3 immunohistochemistry in human hippocampus Figure 5
γ3 immunohistochemistry in human hippocampus. A. The pyramidal cell layer (p) of the CA1 region exhibited moder-
ate to strong staining for γ3. Weak staining was observed in the stratum oriens (o) and stratum radiatum (r). The alveus (a) and 
lacunosum-moleculare (l–m) are in general, absent of immunoreactivity. B. More intense γ3 immunostaining was observed in 
the CA2 and CA3 pyramidal cell layers than in CA1. Strong staining was also detected in CA4 cell bodies but surrounding 
neuropil is devoid of immunoreactivity. C and D. Sections adjacent to those displayed in panels A and B incubated with immu-
nizing peptide-pre-absorbed γ3 Ab. E. Moderate to strong staining of CA1 pyramidal cell bodies and weaker staining in the sur-
rounding neuropil. F. Intense staining of the pyramidal cells of the CA3 with moderate perisomatic staining. G. Cell bodies in 
the subiculum (Sub) are moderately stained and neuropil staining is very weak. Neuropil staining in panels E, F and G may 
reflect relative cell densities in each region. H. Granule cells of the dentate gyrus were stained moderately to strongly by the γ3 
Ab. The immunoreactivity is mainly in the soma of these cells, but can also be seen in the early branches of the granule cells 
dendritic trees, which extend into the lightly stained molecular layer. The neuropil of the polymorphic layer is almost devoid of 
staining. Scale bars in panel A–D represent 250 µm, in panels E–H 25 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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γ4 immunohistochemistry in human hippocampus Figure 6
γ4 immunohistochemistry in human hippocampus. A. γ4 immunoreactivity was seen throughout the pyramidal cell lay-
ers each region of Ammon's horn and the surrounding neuropil with staining most intense in the CA2/3 transition region. 
Labeled regions are as in figures 4 and 5 with the addition of subiculum (s) choroidal fissure (cf) and fimbria (f). B. Section adja-
cent to that in panel A incubated with immunizing peptide pre-absorbed γ4 Ab. C. CA1 pyramidal cell bodies are moderately to 
strongly stained by γ4 Ab with moderate staining in surrounding neuropil. D. Strong staining of pyramidal cells in the CA3 with 
only slightly weaker immunostaining in the neuropil. E. Staining of CA4 cell bodies is moderate to strong with moderate 
neuropil staining. F. Although positively stained, the granule neurons of the dentate gyrus do not stain as strongly for γ4 as do 
pyramidal cells. Scale bars in panel A and B represent 5 mm and in panels C–F 25 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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Ammon's horn strained strongly, with lesser
immunostaining in the subiculum and CA4 regions (Fig-
ure 5A and 5B). Closer examination revealed that the
pyramidal cell bodies stained strongly for γ3 and this stain-
ing was strongest in CA3 and became progressively weaker
through the CA2 and CA1 regions and into the subicu-
lum. High power images of CA1 (Figure 5E), CA3 (Figure
5F), and subiculum (Figure 5G) determined that this was
most likely to be caused by increased cell densities in the
CA2/3 regions rather than more intense staining of
pyramidal neurons, although perisomatic staining was
more intense in the CA3 region than CA1, and absent
from the subiculum. Visible in Figure 5A and 5B, and also
observed at an increased magnification in Figure 5H, the
granule layer of the dentate gyrus is distinctly labeled
whereas the molecular and polymorphic layers display
weak or no immunostaining. The granule cells stained
moderately to strongly for γ3 and the immunoreactivity
was mainly in the soma of these cells, but could also be
seen in the early branches of the granule cell dendritic
trees, which extend into the lightly stained molecular
layer (Figure 5H).
At the macroscopic level, medium to strong γ4 immunos-
taining was seen throughout the pyramidal layers of
Ammon's horn and in the alveus (Figure 6A). The alveus
stained strongly for γ4 as did the cell bodies in the pyram-
idal layer of all CA regions. This was observed more clearly
at high power with a similar high level of staining of
pyramidal cell bodies throughout the CA1-4 regions, but
with the most intense perisomatic staining observed in
the CA2/3 region (Figure, 6C, 6D, and 6E). Weak to mod-
erate staining was observed throughout the neuropil of
the strata surrounding the pyramidal layers in all regions.
In the dentate gyrus, the granule cell layer appears to stain
slightly more strongly than the adjacent molecular or pol-
ymorphic regions (Figure 6F). This also may be an artifact
of the cell density in the granule layer rather than
increased expression of the γ4 protein in the dentate gran-
ule cell bodies compared to their processes.
The effects of γ2 and γ4 on the biophysical properties of 
CaV2.1 calcium channels
Since the role of the stargazin-like proteins in relation to
VDCC function remains controversial we examined the
effects of γ2 and γ4 on the biophysical properties of CaV2.1
calcium channels. Together with the CaV2.1 α subunit, we
co-expressed a β4 subunit with or without an α2δ2 subu-
nit. These VDCC subunits are known to be highly
expressed in cerebellar Purkinje cells [31–38], a cell type
that, according to the immunohistochemistry data pre-
sented herein, strongly expresses both γ2 and γ4. Figure 7A
and 7B show the current-voltage relations of CaV2.1/β4
and CaV2.1/β4/α2δ2  VDCCs respectively, expressed in
Xenopus oocytes either in the presence or absence of γ2 or
γ4. Neither γ2 nor  γ4 produced a statistically significant
shift in the half-maximal voltage of activation (V50act) of
CaV2.1/β4 (Table 1). The slope factor (kact), maximum
conductance (Gmax), and peak current amplitude at +10
mV were also very similar to controls on co-expression of
either γ2 or γ4 in the absence the α2δ2 subunit. Co-expres-
sion of the α2δ2 subunit was sufficient to significantly
increase the Gmax and peak current amplitude of a CaV2.1/
β4 Ca2+ channel complex (Figure 7A and 7B). However,
the increase was not affected by the additional co-expres-
sion of either γ2 or γ4.
No statistically significant differences were observed in
the half-maximal voltage of steady-state inactivation
(V50inact) or slope factor (kinact) of CaV2.1/β4 or CaV2.1/β4/
α2δ2 VDCCs co-expressing γ2 or γ4 (Figure 7C, 7D and 7E
and Table 2).
Discussion
Differential distribution of human stargazin-like γ mRNAs
The northern blot analysis described herein detected the
human γ2, γ3 and γ4 mRNAs only in the brain. Similar
mRNA distributions and transcript sizes have been
reported by in situ hybridization and northern blot for the
mouse orthologues [1,14,19] and these data are
supported by western blots [22]. We do not however rule
out the possibility that human γ2,  γ3  and  γ4  may be
expressed in some non-CNS tissues that are not included
on the multiple tissue northern blot used in this study.
Other laboratories that employed highly sensitive reverse-
transcriptase polymerase chain reaction expression analy-
ses have reported that γ4 in particular is expressed in some
non-neuronal tissues [13,17]. The γ2 and  γ4 transcripts
were detected in most of the brain regions probed and
mainly in the same tissues. However, in some regions
where both isoforms are detected, for example the cerebel-
lum or thalamus, γ2 expression is higher than γ4, whereas
in the basal ganglia regions of putamen and caudate
nucleus  γ4 mRNA is the more highly represented tran-
script. γ3 is much more selectively detected, but its expres-
sion is coincident with both γ2 and γ4 in all regions in
which it was detected by northern blot.
An additional observation was that these stargazin-like γ
proteins are differentially detected in some of the nuclei
that comprise the basal ganglia, a region believed to be
involved in the planning and programming of movement,
or more broadly in the processes by which intention is
converted into voluntary action. The putamen has a heter-
ogeneous neuronal γ population with γ4 mRNA possibly
the most prevalent of the three γ transcripts investigated
herein, as has been previously observed in both mouse
and rat brain [14,25]. The caudate nucleus also expresses
transcripts for all three stargazin-like γ proteins, however
the signal detected with the γ2 probe was extremely weakBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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in comparison to those for γ3 and γ4. On the other hand,
γ2 was the most prevalent species detected in substantia
nigra, with faint detection of γ4 and no γ3 signal. No sig-
nals for any of the γ transcripts were detected in the sub-
thalamic nucleus. Further immunohistochemical and
electrophysiological investigation will be required to elu-
cidate why γ2, γ3 and γ4 have such differential distributions
in these nuclei.
In vitro expression of human stargazin-like proteins and 
antibody specificity
The transient expression of cloned human γ2, γ3 and γ4
cDNAs in COS-7 cells served several purposes: It deter-
Influence of γ2 and γ4 upon CaV 2.1/β4 ± α2δ2 VDCC currents expressed in Xenopus oocytes Figure 7
Influence of γ2 and γ4 upon CaV 2.1/β4 ± α2δ2 VDCC currents expressed in Xenopus oocytes.A The peak current-
voltage relationships for CaV2.1/β4 (n = 16), CaV2.1/β4/γ2 (n = 14) and CaV2.1/β4/γ4 (n = 11) show no significant differences in 
any parameters (Table 1). The bottom panels display representative traces recorded from a single oocyte injected with each 
subunit combination investigated. B. The peak current-voltage relationships for CaV2.1/β4/α2δ2 (n = 43), CaV2.1/β4/α2δ2/γ2 (n 
= 34) and CaV2.1/β4/α2δ2/γ4 (n = 20) show no significant differences in any parameters (Table 1). In both panels A and B, only 
representative traces from -50 to +10 mV are displayed for reasons of clarity. C. Mean steady state inactivation data for IBa 
recorded in 10 mM Ba2+ from Xenopus oocytes injected with CaV2.1/β4/α2δ2 (n = 18) or CaV2.1/β4/α2δγ (n = 18) D. CaV2.1/β4/
α2δ2 (n = 20), or CaV2.1/β4/α2δ2/γ4 (n = 20). Co-expression of either γ2 or γ4 produced data almost identical to the control. E. 
Oocytes injected with CaV2.1/β4 (n = 22), CaV2.1/β4γ2 (n = 16) and CaV2.1/β4γ4 (n = 9) normalized to the maximum current 
Imax and fitted with a single Boltzmann function. The numerical data for parameters defining the steady-state inactivation rela-
tionships are displayed in Table 2.
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mined that the human γ2, γ3 and γ4 cDNA clones expressed
in vitro; it demonstrated the specificity of three anti-γ Abs,
one generated to detect each of the three isoforms; it
revealed that the stargazin-like γ2, γ3 and γ4 all localize to
the plasma membrane of COS-7 cells when expressed
either alone or in combination with other VDCC subunits
and finally it showed that COS-7 cells do not endog-
enously express γ2, γ3 or γ4. Furthermore, because the anti-
γ Abs, all of which were designed to detect epitopes in the
C-terminus after the fourth predicted transmembrane seg-
ment, failed to stain COS-7 cells that had not been
permeablized, it was established that the C-terminus is
localized to the membrane and inside the cell. If predic-
tions of secondary structure as envisaged by other labora-
tories are correct, a tetra-spanning transmembrane
conformation will also place the N-terminus on the cyto-
plasmic side of the membrane [12,16].
The distribution of the γ2, γ3 and γ4 in cerebellum
This study is the first immunohistochemical analysis of
stargazin-like γ proteins in the human CNS. In the cerebel-
lum, we observed that γ2  was detected in molecular,
granule and Purkinje cell layers as has been previously
reported for mouse γ2 protein [22] and mRNA [1,14,19].
A major difference between human and rodent immunos-
taining patterns was observed for γ4, which was detected
as very high levels in human cerebellar Purkinje cell bod-
ies and processes, an observation not reported for rat or
mouse [22,25]. The detection of γ3 protein expression in
the human cerebellum, albeit at extremely low levels, was
similar to the γ3 mRNA detection patterns reported in
mouse or rat cerebellum [19,25] but disagree with the
findings on our northern blots and the in situ hybridiza-
tion data of Klugbauer et al. [14]. The positive, albeit weak
detection of γ3 protein in cerebellar interneurons and low
levels detected in Purkinje cell bodies suggests that γ3 is
Table 1: Characteristics of IBa via CaV2.1/β4 or CaV2.1/β4/α2δ2 with or without γ2 or γ4
Channel Activation n
V0.5act(mV) kact. Gmax (µS) Peak at +10 mV (µA)
CaV2.1/β4 -2.60 ± 0.65 5.39 ± 0.49 8.45 ± 2.20 -0.25 ± 0.05 16
CaV2.1/β4/γ2 -4.27 ± 1.24 4.91 ± 0.52 9.96 ± 3.34 -0.32 ± 0.12 14
CaV2.1/β4/γ4 -5.70 ± 2.26 5.43 ± 0.47 8.16 ± 2.59 -0.26 ± 0.07 11
CaV2.1/β4/α2δ2 -4.60 ± 0.59 4.03 ± 0.15 14.97 ± 2.05 * -0.54 ± 0.08 43
CaV2.1/β4/α2δ2/γ2 -4.13 ± 0.63 4.46 ± 0.14 15.43 ± 1.96 -0.54 ± 0.07 34
CaV2.1/β4/α2δ2/γ4 -5.56 ± 0.60 3.96 ± 0.24 14.8 ± 2.64 -0.56 ± 0.10 20
To analyze the voltage-dependent activation, current-voltage (I-V) relationships (Figure 7A and Figure 7B) were fitted with a modified Boltzmann 
equation (see methods) to calculate V50act, the mid-point of voltage dependence of activation, kact, the slopefactor and Gmax, the maximum 
conductance. Values are expressed as mean ± S. E. M. of the number of replicates, n. One-way analysis of variance (ANOVA) tests determined no 
statistically significant changes in any pairs of data differing by the presence of a γ2 or γ4 P < 0.05 was considered significant). Statistically significant 
differences observed between the CaV2.1/β4 and CaV2.1/β4/α2δ2 channels are indicated by * (P < 0.05).
Table 2: Steady state inactivation properties of CaV2.1/β4 or CaV2.1/β4/α2δ2 with or without γ2 or γ4
Channel Inactivation n
V50inact (mV) kinact
CaV2.1/β4/α2δ2 -31.52 ± 1.58 7.04 ± 0.19 18
CaV2.1/β4/α2δ2/γ2 -33.44 ± 1.49 7.10 ± 0.23 18
CaV2.1/β4/α2δ2 -31.40 ± 0.89 7.04 ± 0.28 20
CaV2.1/β4/α2δ2/γ4 -34.60 ± 1.43 6.61 ± 0.28 20
CaV2.1/β4 -32.40 ± 1.09 8.43 ± 0.61 22
CaV2.1/β4/γ2 -37.30 ± 1.75 7.52 ± 0.74 16
CaV2.1/β4/γ4 -31.50 ± 1.80 8.40 ± 0.92 9
Steady-state inactivation data from Figures 7C, 7D and 7E were fitted with a single Boltzmann function (see methods). Values are expressed as 
mean ± S. E. M. of the number of replicates, n. In the presence of an α2δ2 subunit, neither γ2 nor γ4 caused statistically significant modulation of the 
measured parameters according to an un-paired Student's t-test (P < 0.05 was considered significant). Equally, when the α2δ2 subunit was omitted 
from the injection mixture, ANOVA determined no statistically significant changes in any pairs of data differing by the presence of a γ protein.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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expressed in distinct types of neurons in human cerebel-
lum at levels too low to be detected by some hybridization
conditions.
The almost inverse staining patterns of γ2 and γ4 in the
dentate cerebellar nucleus (DCN) was striking. Much of
the perisomatic neuropil surrounding the DCN somata
consists of afferents from the Purkinje cells and is stained
particularly strongly for γ4 while the DCN cell bodies
stained strongly for γ2 but were devoid of γ4 staining. It is
therefore a reasonable assumption that γ4 is pre-synapti-
cally localized in the Purkinje cell afferents to the DCN
whilst γ2 localizes to the post-synaptic regions of the DCN
cell bodies. Indeed this observation holds with the finding
that γ4 expressed well throughout Purkinje cell processes.
γ4 also appears to be localized in the GABAergic neurons
of the cerebellum more than the excitatory glutamatergic
cell types. In addition to showing strong immunostaining
throughout Purkinje cells, γ4 is detected in the interneu-
rons of the molecular layer and also the Golgi interneu-
rons of the granule layer. Whilst γ2 is also detected in all
these cell types, the γ4  immunostaining is noticeably
lower, if not absent from the excitatory granule cells, and
is absent from the DCN cell bodies.
The distribution of γ2, γ3 and γ4 in hippocampus
This study has determined that γ2, γ3 and γ4 show differen-
tial but overlapping expression patterns in the human
hippocampus and dentate gyrus. As is the case for the cer-
ebellum, the expression patterns of γ2 and γ4 more closely
resemble one another than that of γ3. The γ2, and γ4 pro-
teins were detected throughout the hippocampus and
dentate gyrus, although there were variations in the stain-
ing of cell bodies, dendrites and neuropil in the different
sub-fields. γ3 localized more specifically in the neuronal
cell bodies of the hippocampus and dentate gyrus. This
possibly indicates that γ2 and γ4 are involved in synaptic
modulation of neurotransmission throughout the cell,
whereas γ3 is solely involved in functions such as regula-
tion of VDCCs or AMPA receptors in the cell soma.
CaV2.1/β4 VDCC currents are not modulated by human γ2 
or γ4 co-expression in the presence or absence of an α2δ2 
subunit
The co-expression of γ2 or γ4 with CaV2.1/β4 VDCCs in the
absence or presence of the α2δ2  subunit, did not
significantly affect peak current amplitude or any of the
activation or inactivation properties. These data agree
closely with the findings of Chen et al. [19] who recorded
whole cell Ca2+ currents from stg and wild type cerebellar
granule cells. They reported that absence of γ2 neither
altered the I-V relationship of the native whole cell Ca2+
current nor did it significantly modulate the steady-state
inactivation properties of VDCC current compared to wild
type. Although they did not use pharmacological agents to
isolate specific components of the whole cell Ca2+ current
which might have highlighted subtle changes particular to
the P/Q-, N-, R-, or L-type currents present in this cell type
[39,40], it is unlikely that another known γ isoform could
functionally substitute for γ2 to maintain normal VDCC
function in that instance because distribution studies have
shown that they are probably not expressed in this cell
type [14,19,25]. This indicated that even if γ2 was associ-
ated directly or indirectly with a VDCC complex in cere-
bellar granule cells [20,22], it did not modulate the high
voltage activated VDCC I-V relationship or inactivation
properties.
More recent patch clamp recordings from stg  thalamic
relay neurons showed a 45% increase in HVA VDCC peak
current densities compared to wild type [21] consistent
with a previous report that γ2 inhibited high voltage acti-
vated VDCC peak current amplitude by 37–40% when
expressed in Xenopus oocytes [20]. Why our data and those
of Chen et al. [19] are so different from these results may
be explained by differences in subunit combinations
expressed in granule cells and thalamic relay neurons and
between the two in vitro studies. Stargazin-like proteins
might be able to directly modulate VDCC complexes con-
sisting of particular subunit combinations, but are unable
to reproduce this influence on other subunit complexes if
they required additional interacting proteins not present
in the Xenopus oocyte or cerebellar granule cells. The elec-
trophysiological data therefore cannot be used as a strong
argument to warrant considering these γ proteins as an
integral part of high voltage-activated Ca2+  channels
because modulation of current properties has not been
reproducible between different studies. Nevertheless,
there is biochemical evidence for the association of γ2 and
γ3 with the N-type CaV2.2 channel [20,22] and it is quite
possible that whilst γ2, γ3 and γ4 readily associate with cer-
tain neuronal VDCC complexes, specific environmental
conditions must be met for them to exert a measurable
biophysical influence.
Conclusions
Human γ2, γ3 and γ4 stargazin-like proteins (or TARPs) are
detected solely in the CNS. On the whole, their differen-
tial distributions closely parallel those of their rodent
orthologues as observed by northern blot, in situ hybridi-
zation, western blot and immunohistochemistry
[1,14,19,22,25] with some notable exceptions. The differ-
ential expression pattern of each isoform among the cell
types present in human cerebellum and hippocampus
predicts specific roles for each subtype in neuronal func-
tion, and possibly even segregated VDCC-γ or AMPA
receptor-γ complexes [25]. The results of our electrophys-
iology experiments support the notion that γ2, γ3 and γ4
stargazin-like proteins are not "subunits" of VDCCs in the
true sense of the word. Nevertheless, we do not discountBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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the possibility that they may interact with VDCCs and
possibly influence trafficking, assembly or integration of
VDCCs and AMPA-receptor function in their native envi-
ronment or that to modulate VDCC current they require
other factors not endogenously expressed in Xenopus
oocytes.
Methods
cDNA sources and synthesis
Human brain total RNA was purchased from Invitrogen
(Paisley, UK) and used to generate cDNA using the Super-
script Pre-amplification System (Invitrogen) primed with
random hexamers according to the manufacturer's
instructions.
Isolation and cloning of the γ2, γ3 and γ4 cDNAs
The complete open reading frame (ORF) of human
CACNG2 cDNA was amplified from 25 ng human brain
cDNA by PCR (cycling parameters: 98°C for 1 min, then
30 cycles of 98°C for 30 s, 55°C for 30 s, 72°C for 2 min,
followed by a final 10 min extension step at 72°C) con-
taining Pfu polymerase and 25 pmol each of the gene spe-
cific primers (GSPs), 5'-
GCGGCCGCACCATGGGGCTGTTTGATC-3' and 5'-
GCTAGCCTCGAGTTAGTGTTTATATAATGAAGAA-3'.
These amplify the ORF of CACNG2, with a 5' extension of
a Not I restriction site and partial Kozak sequence for ini-
tiation of translation in vertebrates (ACC) [41] and a 3'
extension of Xho  I and Nhe  I restriction enzyme sites.
Amplified fragments of the correct size were purified from
agarose gels using the Qiaex II kit (Qiagen, Crawley, UK),
and cloned into pCR2.1-TOPO vector (Invitrogen). Posi-
tive colonies identified by blue/white screening were con-
firmed by EcoR I restriction digest of purified plasmid and
were sequenced on both strands using T7 (5'-TAATAC-
GACTCACTAT AGGG-3') and M13R (5'-CAG-
GAAACAGCTATGAC-3') universal primers and gene
specific primers in an automated dye terminator
sequencer (Applied Biosystems, Warrington, UK).
The same procedures used to clone human CACNG2 were
followed to clone CACNG3 and CACNG4, but using the
primer pairs, 5'-CGGCCGCCACCATGAGGATGTGT-
GACAGAGGTA-3' and 5'-GCTAGCCTCGAGTCAGTTCA-
GACGGGCGTGG TG-3' to amplify CACNG3 ORF or, 5'-
GCGGCCGCACCATGGTGCGATGCGACCGCG-3' and
5'-GCTAGCCTCGAGTCACACAGGGGTCGTCCGTC-3' to
amplify CACNG4 ORF. These primer pairs contained the
same restriction enzyme sites and if appropriate, the par-
tial Kozak sequence [41] in their 5' extensions as were
included in the CACNG2 primers. The human γ2, γ3, and
γ4 cDNAs were subcloned into the pMT2 vector for expres-
sion in Xenopus oocytes and COS-7 cells [42].
Other cDNA clones
The following cDNAs were used: rabbit CaV2.1 (X57689),
rat β4 (LO2315) and mouse α2δ2 (AF247139, common
brain splice variant). All cDNAs were subcloned into
expression vector pMT2 [42].
Antibodies
Multiple sequence alignments and basic local alignment
search tool (BLAST) searches compared the protein
sequences of all known stargazin-like γ proteins with one
another and with other proteins in the public databases.
This identified regions of lowest homology between γ2, γ3
and γ4 that were not present in any other known proteins.
The following peptides, TARATDYLQASAITRIPS (γ2,
amino acids 211–228), FHNSTPKEFKESLHNNPAN (γ3,
amino acids 291–309) and VHDFFQQDLKEGFHVSMLN
(γ4, amino acids 303–321), were synthesized by standard
solid-phase techniques at Severn Biotech (Kidderminster,
UK) to generate specific polyclonal antibodies (Abs). Each
was coupled to the carrier protein tuberculin purified pro-
tein derivative (PPD) using sulpho- Succinimidyl4- [N-
maleimidomethyl] cyclohexane-1-carboxylate (SMCC)
(Pierce, Tattenhall, UK) via a Cys residue added at the N-
terminus during synthesis. To raise polyclonal anti-γ2,
anti-γ3 and anti-γ4 Abs, the resulting conjugates were used
to immunize Bacille Calmette-Guerin (BCG)-sensitized
Dutch rabbits at monthly intervals [43]. The immune
response was monitored by indirect enzyme-linked
immunoabsorbent assay (ELISA) with free peptide-coated
micro-titer plates. Immunoglobulins from the terminal
bleeds were purified using immobilized peptide antigen
columns (Sulfo-link, Pierce). Each anti-γ Ab was checked
for specificity for its target by immunocytochemistry.
COS-7 cells transfected with a single stargazin-like γ pro-
tein cDNA were examined for positive staining following
incubation with the appropriate affinity purified Ab. Con-
trol slides were also examined for cross-reaction of the pri-
mary Ab with non-transfected COS-7 cells, stargazin-like γ
proteins other than the target against which the primary
Ab was intended to bind (data not shown) and the VDCC
α1, α2δ, and β subunits used in this investigation. Finally,
positive staining of target protein was abolished following
overnight pre-incubation (at 4°C) of the primary Ab with
a 10 × molar excess of the peptide against which it was
raised (data not shown).
Cell culture and transfections
COS-7 cell were cultured as previously described [44].
Transfection was performed using the Geneporter trans-
fection reagent (Gene Therapy Systems, San Diego, CA).
Cells were plated onto coverslips 2–3 h prior to transfec-
tion. The DNA and Geneporter reagent (2 µg and 10 µl,
respectively) were each diluted in 500 µl of serum-free
medium, mixed, and applied to the cells. The α1, β, α2δ
and γ cDNAs were mixed and transfected in a 1:1:1:1 ratioBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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by DNA weight. If a particular cDNA was absent from the
transfection, substitution with blank pMT2 vector main-
tained correct subunit ratios. After 3.5 h, 1 ml of medium
containing 20% serum was added to the cells, which were
then incubated at 37°C for 3 days. Prior to staining, cells
were re-plated using a non-enzymatic cell dissociation
solution (Sigma, Dorset, UK) and maintained at 27°C for
between 2 and 6 h.
Immunocytochemistry
COS-7 cells were fixed and permeablized for immunocy-
tochemistry essentially as previously described [44]. Pri-
mary Abs, affinity purified anti-γ2, anti-γ3 and anti-γ4 were
used at 0.2 µg/ml. Secondary biotin conjugated or goat
anti-rabbit (Sigma, Dorset, UK) Ab was applied at 5 µg/
ml. Texas red-conjugated streptavidin was applied at 3.3
µg/ml. The nuclear dye 4', 6-diamidino-2-phenylindole
(DAPI, 300 nM, Molecular Probes) was also used to visu-
alize the nucleus. Cells were examined on a confocal scan-
ning laser microscope (Leica TCS SP, Milton Keynes, UK).
All images were scanned sequentially to eliminate cross-
talk and photomultiplier settings kept constant in each
experiment.
Northern blots
Human 12-lane multiple tissue blots and brain II and III
blots (BD Biosciences Clontech) were hybridized at 65° C
in ExpressHyb solution (BD Biosciences Clontech)
according to the manufacturer's instructions. The [α32P]
radiolabeled γ probes corresponding to nucleotides 597–
814, 560–792 or 594–804 of the γ2, γ3 or γ4 ORFs respec-
tively, were assembled according to the Strip-EZ DNA
Probe Synthesis Removal Kit (Ambion (Europe) Ltd,
Huntingdon, UK). The final stringency wash performed
was 0.1 × Saline Sodium Citrate, 0.1% Sodium dodecyl-
sulphate (SDS) at 65°C.
Human Brain Immunohistochemistry
Human brain tissue was obtained from two males aged 76
and 80 years whose causes of death were listed as meta-
static carcinoma and left ventricular failure respectively.
No prior history of brain disease was noted. The tissue,
provided by the Cambridge Brain Bank Laboratory at the
University of Cambridge, U.K., was collected using ethical
consent procedures according to U.K. law. Sections were
fixed in neutral buffered formalin and processed to
paraffin wax. Paraffin-embedded wax blocks were sec-
tioned on a Microm HM3555S microtome at 7 µm and
underwent a microwave antigen retrieval procedure using
a citrate buffer at pH 6.0 prior to immunostaining [45,46].
Endogenous peroxidase was blocked with 3% hydrogen
peroxide in water followed by non-specific protein block-
ing in 5% milk powder in phosphate buffered saline
(PBS). Sections were incubated overnight with primary Ab
(anti-γ2, 0.85 µg/ml; anti-γ3, 1.3 µg/ml; anti-γ4, 0.85 µg/
ml) diluted with 3% goat serum and 0.1% Triton X-100 at
4°C in a moist chamber. Treatment of all sections post
application of primary Ab was identical. Goat anti-rabbit
(1:20 dilution, Biogenex, Wokingham, UK) link Ab was
applied to all sections and incubated at room temperature
for 20 min, followed by horseradish peroxidase-conju-
gated streptavidin (Biogenex, prediluted (1/20)) that was
incubated for a further 20 min. Sections were visualized
using 3,3'-diaminobenzidine (DAB) solution made up
according to Vector kit SK-4100 (Peterborough, UK), and
incubated with the sections for 2–10 min. In a few cases,
sections were counterstained briefly in Mayer's hematoxy-
lin prior to microscopic examination.
Negative control preparations performed in all immuno-
histochemistry experiments included replacement of pri-
mary antibodies with PBS only and preincubation of
primary antibodies with the 100 µM corresponding
immunizing peptide overnight at 4°C prior to
immunostaining.
Microscopy and image analysis
Slides were analyzed using a Zeiss Axioplan Optical
Microscope (Carl Zeiss Ltd., Welwyn Garden City, UK).
All sections were viewed under bright-field illumination
using × 2.5, × 10, × 20, or × 40 objectives and a stabilized
light source. For each tissue section, both The Central
Nervous System [47], and The Human Brain: an introduc-
tion to its functional anatomy [48] were used for refer-
ence, together with corresponding counterstained
sections to locate and define nuclear groups. A JVC KY-
F55B television camera attached to the microscope and a
PC running AcQuis image capture software (Syncroscopy,
Cambridge, UK) was used to obtain images of each
section.
Electrophysiology
Adult female Xenopus laevis were killed by anesthetic over-
dose in a 0.25% solution of tricaine, decapitated, and
pithed. Oocytes were removed and defolliculated by treat-
ment with 2 mg/ml collagenase type IA in Ca2+-free ND96
saline containing (in mM): NaCl, 96; KCl, 2; MgCl2, 1;
and HEPES, 5, pH-adjusted to 7.4 with NaOH for 2 hr at
21°C. Plasmid cDNAs for the different VDCC subunits
were mixed in a weight ratio of 1:1:1:1, and ~10 nl was
injected into the nuclei of stage V or VI oocytes. In control
oocytes without a γ cDNA or in the absence of an α2δ
cDNA, an equal volume of water was substituted in the
mix. Injected oocytes were incubated at 18°C for 3–5 days
in ND96 saline (as above plus 1.8 mM CaCl2) supple-
mented with 100 µg/ml penicillin, 100 IU/ml streptomy-
cin (Invitrogen), and 2.5 mM Na pyruvate. Whole-cell
recordings from oocytes were made in the two-electrode
voltage-clamp configuration under continuous gravity-fed
superfusion (~1 ml/min) with a chloride-free solutionBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
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containing (in mM): Ba(OH)2, 10; TEA-OH, 80; NaOH,
25; CsOH, 2; and HEPES, 5 (pH7.4 with methanesulfonic
acid). In all experiments, oocytes were injected with 30–
40 nl of a 100 mM solution of K3-1, 2-bis (aminophe-
noxy) ethane-N, N, N', N'-tetra-acetic acid (BAPTA) in
order to suppress endogenous Ca2+-activated Cl- currents.
Recording microelectrodes, were pulled from thick-walled
borosilicate glass capillary tubing with the following
dimensions: 1.5 mm outer diameter, 1.0 mm bore diam-
eter and with an internal 0.1 mm fiber (Plowden and
Thompson, Stourbridge, UK). The TEVC pipettes were
pulled using a P-87 Flaming/Brown microelectrode puller
(Sutter Instrument Company, Novato, CA). Electrodes
contained 3M KCl and had resistances of 0.3–2 MΩ. The
holding potential (VH) was -100 mV. Membrane currents
were recorded, amplified, low-pass filtered at 1 kHz using
a Geneclamp 500 B amplifier, digitized through a Digi-
data 1200 interface (Axon Instruments, Foster City, CA)
and stored on a PC using data acquisition software
pClamp 6.02 (Axon Instruments). In all cases currents
were leak subtracted on-line by a P/4 protocol. Additional
analyses including calculation of means, standard error of
the mean (S. E. M.), significance (unpaired Student's t-
tests, where applicable) and curve fitting were calculated
using Origin 5.0 (OriginLab Corporation, Northampton,
MA). One-way analysis of variance (ANOVA) and post-
hoc tests were performed using software available at http:/
/faculty.vassar.edu/lowry/VassarStats.htm. Where mean
values are presented they are shown as mean ± S. E. M.
(with n depicting the number of oocytes from which the
mean was calculated). Statistical significance was defined
as P < 0. 05.
Current-voltage (I-V) relation curves generated from cur-
rents activated by a 200 ms long depolarizing pulse were
fitted with a combined Boltzmann and linear fit function:
I = Gmax (V - Vrev) / (1 + exp(- (V - V50act) / k))             
where I is the whole cell current amplitude, Gmax is the
maximum slope conductance, V0.5act is voltage of the mid-
point of activation, Vrev is the reversal potential and k is
the slope factor for activation.
Steady-state inactivation data were generated from cur-
rents activated by a 100 ms long depolarizing pulse from
the holding potential (VH) to 0 mV immediately after a 25
s conditioning pre-pulse between -100 and 0 mV. Current
amplitudes were normalized to the maximum amplitude
and fitted with a Boltzmann function of the form:
I / Imax = 1 / (1 + exp((V - V50inact) / k))             
where I / Imax is the normalized peak current, V50inact is the
voltage for the mid-point of inactivation, V is the condi-
tioning voltage and k is the slope factor for inactivation.
Authors' contributions
FJM carried out the cloning of the human γ2, γ3 and γ4 pro-
teins, performed all the necessary practical and analytical
procedures to acquire and process the primary data pre-
sented in this paper and drafted the manuscript. ACD and
JJC participated in the conception, design and coordina-
tion of the study. All authors read and approved the final
manuscript.
Acknowledgements
The Medical Research Council as part of an industrial collaborative PhD 
studentship with GlaxoSmithKline supported F. J. M. The Wellcome Trust 
provided additional support. The authors would like to thank Dr M. Rees 
(University College London) for the α2δ2 cDNA and acknowledge the 
assistance of Dr. Carles Cantì (University College London), and Dr. Chris 
Plumpton, Michael Hurle and Margaret Flint (GlaxoSmithKline, Stevenage, 
UK).
References
1. Letts VA, Felix R, Biddlecome GH, Arikkath J, Mahaffey CL, Valen-
zuela A, Bartlett F. S., 2nd, Mori Y, Campbell KP and Frankel WN:
The mouse stargazer gene encodes a neuronal Ca2+channel
γ subunit. Nat Genet 1998, 19:340-347.
2. Catterall WA: Structure and regulation of voltage-gated Ca2+
channels. Annu Rev Cell Dev Biol 2000, 16:521-555.
3. Jay SD, Ellis SB, McCue AF, Williams ME, Vedvick TS, Harpold MM and
Campbell KP: Primary structure of the γ subunit of the DHP-
sensitive calcium channel from skeletal muscle. Science 1990,
248:490-492.
4. Powers PA, Liu S, Hogan K and Gregg RG: Molecular characteri-
zation of the gene encoding the γ subunit of the human skel-
etal muscle 1,4-dihydropyridine-sensitive Ca2+ channel
(CACNLG), cDNA sequence, gene structure, and chromo-
somal location. J Biol Chem 1993, 268:9275-9279.
5. Bosse E, Regulla S, Biel M, Ruth P, Meyer HE, Flockerzi V and Hof-
mann F: The cDNA and deduced amino acid sequence of the
γ subunit of the L-type calcium channel from rabbit skeletal
muscle. FEBS Lett 1990, 267:153-156.
6. Ahern CA, Powers PA, Biddlecome GH, Roethe L, Vallejo P, Morten-
son L, Strube C, Campbell KP, Coronado R and Gregg RG: Modula-
tion of L-type Ca2+ current but not activation of Ca2+ release
by the gamma1 subunit of the dihydropyridine receptor of
skeletal muscle. BMC Physiol 2001, 1:8.
7. Freise D, Held B, Wissenbach U, Pfeifer A, Trost C, Himmerkus N,
Schweig U, Freichel M, Biel M, Hofmann F, Hoth M and Flockerzi V:
Absence of the γ subunit of the skeletal muscle dihydropyri-
dine receptor increases L-type Ca2+ currents and alters
channel inactivation properties.  J Biol Chem 2000,
275:14476-14481.
8. McEnery MW, Snowman AM, Sharp AH, Adams ME and Snyder SH:
Purified omega-conotoxin GVIA receptor of rat brain
resembles a dihydropyridine-sensitive L-type calcium
channel. Proc Natl Acad Sci U S A 1991, 88:11095-11099.
9. Ahlijanian MK, Westenbroek RE and Catterall WA: Subunit struc-
ture and localization of dihydropyridine-sensitive calcium
channels in mammalian brain, spinal cord, and retina. Neuron
1990, 4:819-832.
10. Liu H, De Waard M, Scott VE, Gurnett CA, Lennon VA and Campbell
KP:  Identification of three subunits of the high affinity ω-
conotoxin MVIIC-sensitive Ca2+ channel.  J Biol Chem 1996,
271:13804-13810.
11. Martin-Moutot N, Leveque C, Sato K, Kato R, Takahashi M and Seagar
M: Properties of ω conotoxin MVIIC receptors associated
with α1A calcium channel subunits in rat brain. FEBS Lett 1995,
366:21-25.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/23
Page 17 of 17
(page number not for citation purposes)
12. Black J. L., 3rd and Lennon VA: Identification and cloning of puta-
tive human neuronal voltage-gated calcium channel γ-2 and
γ-3 subunits: neurologic implications.  Mayo Clin Proc 1999,
74:357-361.
13. Chu PJ, Robertson HM and Best PM: Calcium channel γ subunits
provide insights into the evolution of this gene family. Gene
2001, 280:37-48.
14. Klugbauer N, Dai S, Specht V, Lacinova L, Marais E, Bohn G and Hof-
mann F: A family of γ-like calcium channel subunits. FEBS Lett
2000, 470:189-197.
15. Moss FJ, Viard P, Davies A, Bertaso F, Page KM, Graham A, Canti C,
Plumpton M, Plumpton C, Clare JJ and Dolphin AC: The novel
product of a five-exon stargazin-related gene abolishes
CaV2.2 calcium channel expression. Embo J 2002, 21:1514-1523.
16. Burgess DL, Davis CF, Gefrides LA and Noebels JL: Identification
of three novel Ca2+ channel γ subunit genes reveals molecu-
lar diversification by tandem and chromosome duplication.
Genome Res 1999, 9:1204-1213.
17. Burgess DL, Gefrides LA, Foreman PJ and Noebels JL: A cluster of
three novel Ca2+ channel γ subunit genes on chromosome
19q13.4: evolution and expression profile of the γ subunit
gene family. Genomics 2001, 71:339-350.
18. Rousset M, Cens T, Restituito S, Barrere C, Black J. L., 3rd, McEnery
MW and Charnet P: Functional roles of γ2, γ3 and γ4, three new
Ca2+ channel subunits, in P/Q-type Ca2+ channel expressed in
Xenopus oocytes. J Physiol 2001, 532:583-593.
19. Chen L, Chetkovich DM, Petralia RS, Sweeney NT, Kawasaki Y,
Wenthold RJ, Bredt DS and Nicoll RA: Stargazin regulates synap-
tic targeting of AMPA receptors by two distinct
mechanisms. Nature 2000, 408:936-943.
20. Kang MG, Chen CC, Felix R, Letts VA, Frankel WN, Mori Y and
Campbell KP: Biochemical and biophysical evidence for γ2 sub-
unit association with neuronal voltage-activated Ca2+
channels. J Biol Chem 2001, 276:32917-32924.
21. Zhang Yi, Mori Mayra, Burgess Daniel L. and Noebels Jeffrey L.:
Mutations in High-Voltage-Activated Calcium Channel
Genes Stimulate Low-Voltage-Activated Currents in Mouse
Thalamic Relay Neurons. J Neurosci 2002, 22:6362-6371.
22. Sharp AH, Black J. L., 3rd, Dubel SJ, Sundarraj S, Shen JP, Yunker AM,
Copeland TD and McEnery MW: Biochemical and anatomical
evidence for specialized voltage-dependent calcium channel
γ isoform expression in the epileptic and ataxic mouse,
stargazer. Neuroscience 2001, 105:599-617.
23. Chetkovich Dane M., Chen Lu, Stocker Timothy J., Nicoll Roger A.
and Bredt David S.: Phosphorylation of the Postsynaptic Den-
sity-95 (PSD-95)/Discs Large/Zona Occludens-1 Binding Site
of Stargazin Regulates Binding to PSD-95 and Synaptic Tar-
geting of AMPA Receptors. J Neurosci 2002, 22:5791-5796.
24. Choi J, Ko J, Park E, Lee JR, Yoon J, Lim S and Kim E: Phosphoryla-
tion of stargazin by protein kinase A regulates its interaction
with PSD-95. J Biol Chem 2002, 277:12359-12363.
25. Tomita Susumu, Chen Lu, Kawasaki Yoshimi, Petralia Ronald S.,
Wenthold Robert J., Nicoll Roger A. and Bredt David S.: Functional
studies and distribution define a family of transmembrane
AMPA receptor regulatory proteins.  J Cell Biol 2003,
161:805-816.
26. Arikkath J, Chen CC, Ahern C, Allamand V, Flanagan JD, Coronado
R, Gregg RG and Campbell KP: γ1 subunit interactions within the
skeletal muscle L-type voltage-gated calcium channels. J Biol
Chem 2003, 278:1212-1219.
27. Schnell Eric, Sizemore Max, Karimzadegan Siavash, Chen Lu, Bredt
David S. and Nicoll Roger A.: Direct interactions between PSD-
95 and stargazin control synaptic AMPA receptor number.
PNAS 2002, 99:13902-13907.
28. Hashimoto K, Fukaya M, Qiao X, Sakimura K, Watanabe M and Kano
M:  Impairment of AMPA receptor function in cerebellar
granule cells of ataxic mutant mouse stargazer.  J Neurosci
1999, 19:6027-6036.
29. Chen L, Bao S, Qiao X and Thompson RF: Impaired cerebellar
synapse maturation in waggler, a mutant mouse with a dis-
rupted neuronal calcium channel γ subunit. Proc Natl Acad Sci U
S A 1999, 96:12132-12137.
30. Mouritzen Dam A: The density of neurons in the human
hippocampus. Neuropathol Appl Neurobiol 1979, 5:249-264.
31. Volsen SG, Day NC, McCormack AL, Smith W, Craig PJ, Beattie R,
Ince PG, Shaw PJ, Ellis SB, Gillespie A and et al.: The expression of
neuronal voltage-dependent calcium channels in human
cerebellum. Brain Res Mol Brain Res 1995, 34:271-282.
32. Volsen SG, Day NC, McCormack AL, Smith W, Craig PJ, Beattie RE,
Smith D, Ince PG, Shaw PJ, Ellis SB, Mayne N, Burnett JP, Gillespie A
and Harpold MM: The expression of voltage-dependent cal-
cium channel β subunits in human cerebellum. Neuroscience
1997, 80:161-174.
33. Craig PJ, McAinsh AD, McCormack AL, Smith W, Beattie RE, Priest-
ley JV, Yip JL, Averill S, Longbottom ER and Volsen SG: Distribution
of the voltage-dependent calcium channel α1A subunit
throughout the mature rat brain and its relationship to neu-
rotransmitter pathways. J Comp Neurol 1998, 397:251-267.
34. Westenbroek RE, Sakurai T, Elliott EM, Hell JW, Starr TV, Snutch TP
and Catterall WA: Immunochemical identification and subcel-
lular distribution of the α1A subunits of brain calcium
channels. J Neurosci 1995, 15:6403-6418.
35. Tanaka O, Sakagami H and Kondo H: Localization of mRNAs of
voltage-dependent Ca2+channels: four subtypes of α1- and β-
subunits in developing and mature rat brain. Brain Res Mol Brain
Res 1995, 30:1-16.
36. Stea A, Tomlinson WJ, Soong TW, Bourinet E, Dubel SJ, Vincent SR
and Snutch TP: Localization and functional properties of a rat
brain α1A calcium channel reflect similarities to neuronal Q-
and P-type channels.  Proc Natl Acad Sci U S A 1994,
91:10576-10580.
37. Hobom M, Dai S, Marais E, Lacinova L, Hofmann F and Klugbauer N:
Neuronal distribution and functional characterization of the
calcium channel α-2 subunit. Eur J Neurosci 2000, 12:1217-1226.
38. Barclay J, Balaguero N, Mione M, Ackerman SL, Letts VA, Brodbeck J,
Canti C, Meir A, Page KM, Kusumi K, Perez-Reyes E, Lander ES, Fran-
kel WN, Gardiner RM, Dolphin AC and Rees M: Ducky mouse
phenotype of epilepsy and ataxia is associated with muta-
tions in the Cacna2d2 gene and decreased calcium channel
current in cerebellar Purkinje cells.  J Neurosci 2001,
21:6095-6104.
39. Randall A and Tsien RW: Pharmacological dissection of multi-
ple types of Ca2+ channel currents in rat cerebellar granule
neurons. J Neurosci 1995, 15:2995-3012.
40. Pearson HA, Sutton KG, Scott RH and Dolphin AC: Characteriza-
tion of Ca2+ channel currents in cultured rat cerebellar gran-
ule neurones. J Physiol 1995, 482 ( Pt 3):493-509.
41. Kozak M: An analysis of 5'-noncoding sequences from 699 ver-
tebrate messenger RNAs. Nucleic Acids Res 1987, 15:8125-8148.
42. Swick AG, Janicot M, Cheneval-Kastelic T, McLenithan JC and Lane
MD: Promoter-cDNA-directed heterologous protein expres-
sion in Xenopus laevis oocytes. Proc Natl Acad Sci U S A 1992,
89:1812-1816.
43. Lachmann PJ, Strangeways L, Vyakarnam A and Evan G: Raising anti-
bodies by coupling peptides to PPD and immunizing BCG-
sensitized animals. Ciba Found Symp 1986, 119:25-57.
44. Brice NL, Berrow NS, Campbell V, Page KM, Brickley K, Tedder I and
Dolphin AC: Importance of the different β subunits in the
membrane expression of the α1A and α2 calcium channel
subunits: studies using a depolarization-sensitive α1A
antibody. Eur J Neurosci 1997, 9:749-759.
45. McKee PH, Hobbs C and Hall PA: Antigen retrieval by micro-
wave irradiation lowers immunohistological detection
thresholds. Histopathology 1993, 23:377-379.
46. Shi SR, Key ME and Kalra KL: Antigen retrieval in formalin-fixed,
paraffin-embedded tissues: an enhancement method for
immunohistochemical staining based on microwave oven
heating of tissue sections. J Histochem Cytochem 1991, 39:741-748.
47. Brodal Per: The Central Nervous System. 2ndth edition. Oxford,
Oxford University Press; 1998. 
48. Nolte J: The Human Brain: an introduction to its functional
anatomy. 5thth edition. London, Mosby; 2001. 